Introduction
Atypical Hemolytic Uremic Syndrome (aHUS) is a rare but severe condition that affects the complement system, leading to thrombotic microangiopathy and potential organ damage. Given the complexities of managing aHUS during a SARS-CoV-2 infection, this case study explores the successful use of convalescent plasma therapy in a patient with aHUS and COVID-19.
Visit HSPIOA for more groundbreaking research in this field.
Case Presentation
A 52-year-old female with a history of aHUS, genetic mutations in C3 and complement factor H (CFH), and prior kidney transplantation was diagnosed with COVID-19. Despite initially mild symptoms, her condition worsened with respiratory failure, requiring ICU support.
Treatment Approach
The patient was treated with:
Azithromycin (500 mg daily for 2 weeks)
Dexamethasone (6 mg daily for 16 days)
Enoxaparin (4,000 UI/daily for 50 days)
Ceftriaxone (2 g IV for 16 days)
Given the progression to severe pneumonia, a rescue therapy was initiated using hyperimmune plasma (HP) derived from a recovered SARS-CoV-2 patient.
Key Outcomes
Improved Oxygenation – PO2/FiO2 ratio increased from 84 to 224 after the second plasma infusion.
Reduced Inflammation – CRP and IL-6 levels significantly decreased.
No aHUS Recurrence – No signs of hemolysis or thrombotic events were observed.
Complete Recovery – The patient was discharged after 55 days with full resolution of pneumonia.
Clinical Significance
The use of convalescent plasma therapy as a rescue treatment for COVID-19 in aHUS patients demonstrated promising results with no risk of disease relapse. This case adds to the growing evidence supporting HP in immunocompromised patients.
The American Society of Hematology (ASH) emphasizes the role of plasma therapy in severe viral infections. Read more on their official site.
Conclusion
This case suggests that early intervention with convalescent plasma therapy in aHUS patients with COVID-19 may improve outcomes. However, further clinical trials are needed to validate these findings.
Read the full study at https://doi.com/10.29328/journal.jcn.1001088.
Join the Discussion!
Share your thoughts below.
Explore more studies at HSPIOA.
Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article
Heighten Science Publications Inc. 
Leave a comment